Infervision (2026)

10/06/2025

Big news! WHO just gave Infervision's InferRead DR Chest its official stamp of approval for TB screening worldwide! This is the first AI system to earn this honor after proving it works as well as expert radiologists. 🏆
What makes this huge:
✅ Detected over millions of real patients across 3 continents (Africa, Central Asia, Latin America)
✅ Works in places with no radiologists, spotting TB in seconds!
✅ Work along with radiologists detecting 20+ lung abnormalities in one scan - from nodules/ lung cancer, pneumonia, as well as cardiovascular diseases
"Before InferRead DR Chest arrived, we missed most TB cases until it was too late," says a doctor in rural Kenya. "Now we catch them early enough to save lives."
Have you or your loved ones ever waited weeks to see a specialist? InferRead DR Chest delivers results in minutes, not months.
(Disclaimer:some features are for research purpose only)
Read more: https://global.infervision.com/publications.

23/05/2025

Nigerian miners who've never seen a doctor are now getting life-saving TB screenings in minutes. Our InferRead DR Chest is detecting cases that would have been death sentences just months ago. 🇳🇬🩺
and are transforming care in northeast Nigeria's remote mining communities using Infervision's InferRead DR Chest and InferAir ultra-portable X-ray system.
Why this matters: Nigeria carries Africa's highest TB burden, with miners at extreme risk due to dust exposure and virtually no healthcare access. Many have never received medical screening of any kind. 😔
Infervision's technology is breaking through barriers:
✅ InferAir sets up in just 5 minutes in the field
✅ InferRead DR Chest screens over 200 people daily
✅ Both systems operate without internet connectivity
Before Infervision's technology arrived, we had no way to screen for TB in these communities. Now we're finding cases that would have gone undetected," shares , project coordinator.
Have you witnessed how technology can bridge healthcare gaps in remote communities? What other populations could benefit from Infervision's portable diagnostic solutions?
Infervision's InferRead DR Chest and InferAir are accessible through major global health procurement channels (GDF Catalog, Global Fund, UNDP).
Read more: https://global.infervision.com/publications.

17/05/2025

Proud! - Infervision's InferRead DR Chest and InferAir technology are transforming TB detection across Kyrgyzstan, delivering remarkable results in just one year! 🩺🇰🇬
Our impact with Kyrgyzstan's National TB Program:
🫁 10,125 people screened in remote regions
🔍 51 TB cases detected that would have been missed
💪 Bringing AI diagnostics where radiologists can't reach
"With InferRead DR Chest, I think that over the next five years, the workload of a radiologist will be drastically reduced." - Dr. Umaralieva Zuura, Bishkek TB Hospital
Following this success, Kyrgyzstan is scaling up with additional Infervision InferAir systems throughout 2025!
Watch below: https://www.youtube.com/watch?v=DIEXHfzbDu0🤝
Read more: https://global.infervision.com/publications.

11/05/2025

📊 Struggling to Keep Up with the Numbers? Meet Infervision's InferCare - our integrated platform designed for advanced program management. Beyond AI-powered detection, we want to facilitate partners in managing their screening data to ensure analytics-powered impact that reaches those who need it most! 📱💉
What makes Infervision's InferCare essential for TB program managers: 🌟
✅ End-to-End Visibility: Track patient journeys from registration through Infervision's AI screening, radiologist interpretation, and diagnostic test results in one unified interface - no more lost patients or missed follow-ups! 👨‍👩‍👧‍👦🔍
✅ Actionable Program Analytics: Monitor total registrations, InferRead DR Chest AI results, interpretation and diagnostics at a glance with beautiful dashboards that tell the real story of your impact 📈🎯
✅ Flexible Reporting: Generate custom reports from Infervision's InferCare at both program and site levels across any timeframe, with easy Excel export for donor reporting - making accountability simple! 📑💻
Infervision's InferCare seamlessly integrates with our InferRead DR Chest and InferAir solutions, creating a complete ecosystem for TB program management in even the most challenging environments. 🔄✨
Interested in seeing how Infervision's InferCare can revolutionize your TB program management? Reach out for more information! 📲
Read more: https://global.infervision.com/publications.

05/05/2025

Proud to share how Infervision's cutting edge technology, paired with our partner 's ultra-portable X-rays, is powering life-saving screening in Pakistan's most vulnerable communities! 🏥🏍️ just spotlighted this groundbreaking work!
is doing incredible work ensuring TB detection reaches those who've never had access before - coal miners, brick kiln workers, and villagers in Pakistan's most isolated regions. 👷‍♂️👨‍🌾
Why Infervision's technology is making a life-changing difference: 💫
✅ Ultra-Portable: X-ray units paired with Infervision's InferRead DR Chest can be transported by motorbike to locations never before reached by medical imaging! 🏍️📱
✅ No Power, No Problem: Conduct 200+ X-rays analyzed by InferRead DR Chest on battery power alone before needing to recharge - perfect for areas with unreliable electricity 🔋⚡
✅ Reaching the Unreachable: Dopasi Foundation brings Infervision's InferRead DR Chest directly to populations with the highest TB risk but lowest healthcare access 🌄🔬
The impact? Infervision's InferRead DR Chest is helping reduce the estimated 133 TB deaths occurring daily in Pakistan. How many families will keep their loved ones because of early detection? 💔
Read more about how Infervision's InferRead DR Chest is transforming TB care in Pakistan's most challenging environments: https://bit.ly/4hkG1GT
Read more: https://global.infervision.com/publications.

29/04/2025

Deployed in over 1000+ hospitals and imaging centers, Infervision's InferRead CT Lung is transforming early detection with unprecedented precision that doctors trust. 🫁🔍 Could this be the breakthrough we've been waiting for?
Why leading healthcare providers worldwide choose Infervision's InferRead CT Lung: 🏆
✅ Proven Clinical Impact: InferRead CT Lung achieves 95% accuracy detecting malignancies and 93% accuracy for adenocarcinomas, with studies showing 35% reduction in missed nodules compared to traditional methods! 📊🔬
✅ Workflow Efficiency: Radiologists using InferRead CT Lung experience 33% reduction in reading time compared to standard practice, allowing more patients to receive care. ⏱️👨‍⚕️
✅ Comprehensive Analysis: InferRead CT Lung automatically detects, quantifies, and classifies lung nodules while measuring growth over time for intelligent follow-up recommendations. 📈🧠
✅ Global Regulatory Trust: InferRead CT Lung is fully certified with FDA, CE (MDR), UKCA, and NMPA approvals - meeting the highest standards worldwide. 🌐✅
Has your facility struggled with early lung cancer detection or radiologist workload? How might InferRead CT Lung's 35% reduction in missed nodules impact patient outcomes at your institution? 🤔
See Infervision's InferRead CT Lung in action - contact us to book your free demo today: https://bit.ly/3DuY53i 🚀
Read more: https://global.infervision.com/publications.

23/04/2025

In remote islands of the Philippines where healthcare seems a distant dream, our InferVision's AI software, InferRead, is detecting tuberculosis and saving lives that would otherwise be lost to silence. 🏝️🩺
Our recent partnership with , , and brought critical lung disease screening to isolated Bantayan communities where medical care rarely reaches.
What happens when cutting-edge technology meets humanitarian need? Our 25kg InferAir traveled by boat between islands, bringing hospital-grade diagnostics to people who've never had access before.
🌊 Island Challenges Overcome:
Geographic isolation cutting communities off from basic healthcare
Virtually no access to diagnostic equipment or specialist physicians
✨ Mission Impact:
We screened over 130 villagers across two remote islands, providing immediate TB diagnosis and specialist referrals for 102 individuals with lung abnormalities—people who might have gone undiagnosed for years.
"By having these AI-powered tools accessible and available, we bring healthcare to people and that is what matters the most." - Tinsay
Have you witnessed how technology can bridge healthcare gaps in remote communities? What other medical innovations do you believe could transform care in underserved regions?
Discover the full story of how portable AI is changing rural healthcare forever: https://bit.ly/43JAhDk

17/04/2025

Breaking news! Infervision's InferRead DR Chest is changing the game for radiologists worldwide, detecting pneumonia, lung cancer, tuberculosis, and dozens of other conditions from a single chest X-ray! 🫁📱 Imagine catching life-threatening diseases that might otherwise go unnoticed.
What makes Infervision's InferRead DR Chest truly revolutionary? 🌟
✅ Accessible globally through official health channels (GDF, Global Fund, UNDP) bringing advanced diagnostics to underserved regions 🌍
✅ Field-tested and proven effective in resource-limited settings where specialist radiologists are scarce 🏥
✅ Scientifically validated with groundbreaking studies published in Nature and Lancet - the gold standards of medical research 📊
✅ Fully CE certified, meeting the highest European regulatory standards for medical devices ⭐
Has your facility experienced the challenges of limited radiologist availability? How would InferRead DR Chest's instant analysis transform your patient care workflow? 🤔
See Infervision's InferRead DR Chest in action - book your free, no-obligation demo by dropping us a message today! ⚡
(Disclaimer:some features are for research purpose only)

11/04/2025

Ready to see the future of medicine? From detecting hidden tumors to planning life-saving surgeries, Infervision's is transforming patient care in ways we never thought possible. 🩺✨
🔍 Multi-organ mastery: Infervision's AI solutions detect abnormalities across lung 🫁, heart ❤️, brain 🧠, and bone 🦴 systems with precision that rivals specialists, while revolutionizing surgical planning.
🏆 Proven performance: External validations confirm what our users already know - Infervision's InferRead DR Chest, InferRead CT Lung, and InferRead CT Coronary deliver exceptional accuracy when it matters most! 📊💯
🌐 Trust worldwide: With FDA, CE, PMDA, UKCA, and NMPA approvals, Infervision's InferRead product line meets the strictest global standards. Would you expect anything less for your health? 🌎🔐
🚀 Real impact: Infervision's InferRead DR Chest, InferRead CT Lung, and InferRead CT Coronary are already transforming care in 30+ countries and expanding rapidly! How many lives have been touched? The numbers grow daily. 📈👨‍👩‍👧‍👦
Have you experienced Infervision's InferRead diagnostic solutions in your healthcare journey? What would it mean to have potentially life-threatening conditions caught earlier by InferRead technology? 🤔
Curious about bringing Infervision's InferRead product line to your facility? Let's talk about how these AI solutions can enhance your clinical practice! 💬

05/04/2025

Every second, someone in world has a heart attack. 💔 Our InferRead CT Coronary technology is now helping cardiologists spot dangerous blockages before it's too late. ❤️🔍 🩺
Did you know that our InferRead CT Coronary technology can detect coronary artery blockages with over 90% accuracy? 🤯 In a groundbreaking multi-center evaluation, our technology demonstrated:
✅91.9% sensitivity
🎯 97.3% specificity
This means fewer missed diagnoses and more lives potentially saved through early intervention! 🙌 💪
Our AI doesn't replace cardiologists—it empowers them. 🦸‍♀️🦸‍♂️ By providing interpretation assistance, InferRead CT Coronary helps clinicians make faster, more confident decisions when time matters most. ⚡️ 🧠
Have you or someone you love benefited from early cardiac intervention? 🤔 What role do you think AI should play in the future of preventative cardiology? 💭
Explore the science that's transforming cardiac care: https://bit.ly/3FcIi9Y 🔬 🔮

14/11/2024

Community connect session during

It was great to hear about the incredible progress being made in with the support of StopTB partnership, DOPASI Foundation, SIUI Healthcare and Sinopharm in implementing InferVision’s AI for enhanced TB screening in hard-to-reach populations.

This collaborative effort is driving meaningful impact in the fight against tuberculosis, bringing innovative solutions to where they’re needed most.

14/11/2024

Day 1 at - A Great Start!

The first day of the exhibition has been incredibly busy, filled with insightful conversations and exciting opportunities. It's been fantastic connecting with so many industry professionals, exchanging ideas, and exploring new possibilities.

We’re already looking forward to another productive day tomorrow as we continue to engage and collaborate. Stay tuned for more updates!

Infervision

10/06/2025

23/05/2025

17/05/2025

11/05/2025

05/05/2025

29/04/2025

23/04/2025

17/04/2025

11/04/2025

05/04/2025

14/11/2024

14/11/2024

Address

Telephone

Website

Alerts

Contact The Business

Shortcuts

Share